09921021falseother human health activities2024-04-012025-03-31http://www.companieshouse.gov.uk/2024-03-31http://www.companieshouse.gov.uk/pt:PlantMachinery2024-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2024-03-31http://www.companieshouse.gov.uk/cd:Director12024-04-012025-03-31http://www.companieshouse.gov.uk/pt:PlantMachinery2025-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2025-03-31http://www.companieshouse.gov.uk/cd:Director22024-04-012025-03-31http://www.companieshouse.gov.uk/pt:FurnitureFittings2024-03-31http://www.companieshouse.gov.uk/cd:Director32024-04-012025-03-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2024-03-31http://www.companieshouse.gov.uk/pt:FurnitureFittings2025-03-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12024-04-012025-03-31http://www.companieshouse.gov.uk/pt:MotorCars2024-03-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2025-03-31http://www.companieshouse.gov.uk/cd:RegisteredOffice2024-04-012025-03-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass22024-04-012025-03-31http://www.companieshouse.gov.uk/pt:MotorCars2025-03-31http://www.companieshouse.gov.uk/pt:NetGoodwill2024-03-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass32024-04-012025-03-31http://www.companieshouse.gov.uk/pt:NetGoodwill2025-03-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2024-04-012025-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2025-03-31http://www.companieshouse.gov.uk/pt:NetGoodwill2024-04-012025-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-03-31http://www.companieshouse.gov.uk/2024-04-012025-03-31http://www.companieshouse.gov.uk/2024-03-31http://www.companieshouse.gov.uk/cd:FRS1022024-04-012025-03-31http://www.companieshouse.gov.uk/2025-03-31http://www.companieshouse.gov.uk/cd:FullAccounts2024-04-012025-03-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2024-04-012025-03-31iso4217:GBPxbrli:sharesxbrli:pure

Registered number: 09921021

Active Pharmacare Limited

ACCOUNTS

FOR THE YEAR ENDED 31/03/2025

Prepared By:

Montague Kaye

Accountants & Statutory Auditors

82

Reddish Road

Reddish

Stockport

SK5 7QU

Active Pharmacare Limited

ACCOUNTS

FOR THE YEAR ENDED 31/03/2025

DIRECTORS

G Sandher

M Sandher

S Sandher

REGISTERED OFFICE

The Willows Nursing Home

1 Murray Street

Salford

Greater Manchester

M7 2DX

COMPANY DETAILS

Private company limited by shares registered in EW - England and Wales, registered number 09921021

ACCOUNTANTS

Montague Kaye

Accountants & Statutory Auditors

82

Reddish Road

Reddish

Stockport

SK5 7QU

Active Pharmacare Limited

ACCOUNTS
FOR THEYEARENDED31/03/2025
CONTENTS
		Page
Directors' Report		-
Statement Of Comprehensive Income		-
Balance Sheet		3
Notes To The Accounts		4
The following do not form part of the statutory financial statements:
Trading And Profit And Loss Account		-
Profit And Loss Account Summaries		-

Active Pharmacare Limited

BALANCE SHEET AT 31/03/2025
						2025				2024
		Notes				£				£
FIXED ASSETS
Intangible assets		2				1,056,739				315,570
Tangible assets		3				92,362				106,504
						1,149,101				422,074
CURRENT ASSETS
Stock				143,160				95,878
Debtors		5		1,281,541				915,669
Cash at bank and in hand				267,617				145,142
				1,692,318				1,156,689
CREDITORS: Amounts falling due within one year		6		1,602,239				1,021,178
NET CURRENT ASSETS						90,079				135,511
TOTAL ASSETS LESS CURRENT LIABILITIES						1,239,180				557,585
CREDITORS: Amounts falling due after more than one year		7				780,721				199,545
NET ASSETS						458,459				358,040
CAPITAL AND RESERVES
Called up share capital		9				100				100
Profit and loss account						458,359				357,940
SHAREHOLDERS' FUNDS						458,459				358,040
For the year ending 31/03/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 30/12/2025 and signed on their behalf by
.............................
M Sandher
Director

Active Pharmacare Limited

NOTES TO THE ACCOUNTS

FOR THE YEAR ENDED 31/03/2025

1. ACCOUNTING POLICIES

1a. Basis Of Accounting

The accounts have been prepared under the historical cost convention.

The accounts have been prepared in accordance with FRS102 - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .

1b. Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Plant and Machinery		reducing balance 25%
Fixtures and Fittings		reducing balance 15%
Equipment		reducing balance 25%
Motor Cars		reducing balance 25%

1c. Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.

When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs.

1d. Pension Costs

The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year.

1e. Goodwill

Goodwill arising in connection with the acquisition of businesses is capitalised and amortised over its estimated economic life to a maximum of 10 years. Goodwill is reviewed annually for impairment if events or changes in circumstances indicate that the carrying value may not be recoverable.

Active Pharmacare Limited

2. INTANGIBLE FIXED ASSETS
		Purchased
		Goodwill		Total
		£		£
Cost
At 01/04/2024		450,816		450,816
Additions		850,001		850,001
At 31/03/2025		1,300,817		1,300,817
Depreciation
At 01/04/2024		135,246		135,246
For the year		108,832		108,832
At 31/03/2025		244,078		244,078
Net Book Amounts
At 31/03/2025		1,056,739		1,056,739
At 31/03/2024		315,570		315,570

3. TANGIBLE FIXED ASSETS
		Plant and		Fixtures
		Machinery		and Fittings		Equipment		Motor Cars		Total
		£		£		£		£		£
Cost
At 01/04/2024		70,948		110,224		13,967		86,235		281,374
Additions		6,704		320		13,459		-		20,483
Disposals		-		-		-		(46,400)		(46,400)
At 31/03/2025		77,652		110,544		27,426		39,835		255,457
Depreciation
At 01/04/2024		47,835		55,564		9,163		62,308		174,870
Disposals		-		-		-		(30,837)		(30,837)
For the year		6,064		5,870		2,428		4,700		19,062
At 31/03/2025		53,899		61,434		11,591		36,171		163,095
Net Book Amounts
At 31/03/2025		23,753		49,110		15,835		3,664		92,362
At 31/03/2024		23,113		54,660		4,804		23,927		106,504

4. STOCK				2025		2024
				£		£
Stock comprises:
Stock				143,160		95,878
				143,160		95,878

Active Pharmacare Limited

5. DEBTORS				2025		2024
				£		£
Amounts falling due within one year
Trade debtors				705,265		491,580
VAT				151,812		100,644
PAYE control				5,002		1,524
Amounts due from related parties				410,673		314,693
Prepayments				8,789		7,228
				1,281,541		915,669

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
				2025		2024
				£		£
UK corporation tax				103,117		56,011
Salaries and wages control				17,085		180
Directors loan account				230,423		182,825
Bank Loan				87,267		18,587
Trade creditors				399,434		265,518
Pension schemes				922		443
Accruals				3,000		2,500
Amounts due to related parties				760,991		495,114
				1,602,239		1,021,178

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
				2025		2024
				£		£
Bank loans (secured) >1yr				780,721		199,545
				780,721		199,545
The bank loan is secured by legal charges and a debenture between the company and Lloyds Bank PLC in the form of fixed and floating charges over the company's assets.

Active Pharmacare Limited

8. EMPLOYEES
				2025		2024
				No.		No.
Average number of employees				24		13

9. SHARE CAPITAL				2025		2024
				£		£
Allotted, issued and fully paid:
50 Ordinary A shares of £1 each				50		50
40 Ordinary B shares of £1 each				40		40
10 Ordinary C shares of £1 each				10		10
				100		100

10. RELATED PARTY TRANSACTIONS

During the current and previous year the company was under the control of the directors Mr G Sandher, Mr M Sandher and Mrs S Samra. At the balance sheet date £410,673 (2024 - £314,693) was owed by Active Pharmacare Properties Limited, a company in which the directors, Mr G Sandher and Mr M Sandher, are equal shareholders. The loan is interest free and repayable on demand. At the balance sheet date £760,991 (2024 - £495,114) was owed to Unity Homes Limited, a company in which the directors Mr M Sandher has a 49.9% shareholding and Mr G Sandher a 0.2% shareholding. The loan is interest free and repayable on demand.